Weight change, genetics and antiepileptic drugs

@article{Chukwu2014WeightCG,
  title={Weight change, genetics and antiepileptic drugs},
  author={J. Chukwu and N. Delanty and D. Webb and G. Cavalleri},
  journal={Expert Review of Clinical Pharmacology},
  year={2014},
  volume={7},
  pages={43 - 51}
}
  • J. Chukwu, N. Delanty, +1 author G. Cavalleri
  • Published 2014
  • Medicine
  • Expert Review of Clinical Pharmacology
    • Weight gain caused by antiepileptic drugs (AEDs) constitutes a serious problem in the management of people with epilepsy. AEDs associated with weight gain include sodium valproate, pregabalin and vigabatrin. Excessive weight gain can lead to non-compliance with treatment and to an exacerbation of obesity-related conditions. The mechanisms by which AEDs cause weight gain are not fully understood. It is likely that weight change induced by some AEDs has a genetic underpinning, and recent… CONTINUE READING
    View on Taylor & Francis
    ncbi.nlm.nih.gov
    17 Citations
    Background Citations
    5
    17 Citations
    Citation Type

    Citation Type

    [Pharmacogenetic markers of metabolic disorders in the treatment with valproic acid].
    Modern pharmacological treatment of obese patients
    • 7
    Effects of Paullinia cupana extract on lamotrigine pharmacokinetics in rats: A herb-drug interaction on the gastrointestinal tract with potential clinical impact.
    • 7
    Short-term effects of Garcinia cambogia extract on the pharmacokinetics of lamotrigine given as a single-dose in Wistar rats.
    • 4
    Ketogenic diet in epileptic children: impact on lipoproteins and oxidative stress
    • 8
    Pharmacotherapeutic strategies for treating binge eating disorder. Evidence from clinical trials and implications for clinical practice
    • 7
    Pharmacogenetic Markers for Metabolic Impairments in Treatment with Valproic Acid
    Safety evidence on the administration of Fucus vesiculosus L. (bladderwrack) extract and lamotrigine: data from pharmacokinetic studies in the rat
    • 1
    The role of obesity in cognitive dysfunction in people with epilepsy
    • 13
    • PDF
    Evaluation of the effects of Citrus aurantium (bitter orange) extract on lamotrigine pharmacokinetics: Insights from in vivo studies in rats.
    • 1

    References

    SHOWING 1-10 OF 123 REFERENCES
    Effect of Antiepileptic Drugs on Bodyweight
    • 111
    Metabolic concerns associated with antiepileptic medications
    • 104
    Weight-reducing side effects of the antiepileptic agents topiramate and zonisamide.
    • 41
    Low serum leptin level is associated with zonisamide-induced weight loss in overweight female epilepsy patients
    • 6
    Weight gain associated with valproate in childhood.
    • 75
    [Changes of body weight and galanin in epileptic children treated with topiramate].
    • 6
    Topiramate-induced weight loss: A review
    • 78
    Weight issues for people with epilepsy—A review
    • 147
    Bodyweight Gain and Anticonvulsants
    • 104
    Valproic Acid related metabolic syndrome in patients with epilepsy.
    • 9